{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 8,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 3
      },
      "2": {
        "core": 1,
        "branch": 3
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A13 → ¬A12)",
        "prover9_expression": "(fast_track_status(trial_alpha) -> -regulatory_approval(trial_alpha))",
        "natural": "If trial alpha has fast-track status, then regulatory approval for trial alpha is not granted."
      },
      {
        "id": "Rule2",
        "formal": "(A15 → A14)",
        "prover9_expression": "(dosing_complete(trial_alpha) -> patient_recruitment(trial_alpha))",
        "natural": "Provided that dosing is complete for trial alpha, patient recruitment for trial alpha has occurred."
      },
      {
        "id": "Rule3",
        "formal": "(A16 → A15)",
        "prover9_expression": "(analysis_complete(trial_alpha) -> dosing_complete(trial_alpha))",
        "natural": "Whenever analysis is complete for trial alpha, dosing for trial alpha is complete."
      },
      {
        "id": "Rule4",
        "formal": "(A2 → (¬G → ¬A1))",
        "prover9_expression": "(phase1_complete(trial_alpha) -> (-fda_oversight(trial_alpha) -> -approved(drug_x)))",
        "natural": "If phase 1 of trial alpha is complete, then in the absence of FDA oversight for trial alpha, drug X is not approved."
      },
      {
        "id": "Rule5",
        "formal": "(A22 → A21)",
        "prover9_expression": "(monitoring_complete(trial_alpha) -> gcp_trained(dr_smith))",
        "natural": "Assuming monitoring is complete for trial alpha, Dr. Smith is trained in Good Clinical Practice."
      },
      {
        "id": "Rule6",
        "formal": "(A24 → ¬A23)",
        "prover9_expression": "(audit_clean(trial_alpha) -> -data_audit(trial_alpha))",
        "natural": "If the audit for trial alpha is clean, then it is not the case that a data audit was conducted for trial alpha."
      },
      {
        "id": "Rule7",
        "formal": "(A25 → ¬A12)",
        "prover9_expression": "(market_approval(drug_x) -> -regulatory_approval(trial_alpha))",
        "natural": "In the event that market approval is granted for drug X, regulatory approval for trial alpha is not granted."
      },
      {
        "id": "Rule8",
        "formal": "(A27 ∨ (¬(¬(¬(A9 → A10) → ¬A11) → A25) → A26))",
        "prover9_expression": "(competitor_advantage(drug_y) | (-(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> market_approval(drug_x)) -> patent_filed(drug_x)))",
        "natural": "Either competitor drug Y has an advantage, or if it is not the case that whenever Dr. Smith is certified as a researcher, the protocol was followed in trial alpha, and this leads to the data from trial alpha not being valid, then market approval for drug X results in a patent being filed for drug X."
      },
      {
        "id": "Rule9",
        "formal": "(A28 → ¬A11)",
        "prover9_expression": "(publication_pending(trial_alpha) -> -data_valid(trial_alpha))",
        "natural": "Should a publication be pending for trial alpha, the data from trial alpha is not valid."
      },
      {
        "id": "Rule10",
        "formal": "(A3 → (¬G → ¬A1))",
        "prover9_expression": "(phase2_complete(trial_alpha) -> (-fda_oversight(trial_alpha) -> -approved(drug_x)))",
        "natural": "If phase 2 of trial alpha is complete, then given that there is no FDA oversight for trial alpha, drug X is not approved."
      },
      {
        "id": "Rule11",
        "formal": "(A30 → (A29 ∨ (¬(A9 → A10) → A28)))",
        "prover9_expression": "(media_coverage(trial_alpha) -> (conference_presentation(trial_alpha) | (-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> publication_pending(trial_alpha))))",
        "natural": "Whenever there is media coverage for trial alpha, either a conference presentation was made for trial alpha, or if Dr. Smith is not certified as a researcher implying the protocol was followed in trial alpha, then a publication is pending for trial alpha."
      },
      {
        "id": "Rule12",
        "formal": "(A30 ∨ A31)",
        "prover9_expression": "(media_coverage(trial_alpha) | investor_interest(trial_alpha))",
        "natural": "Either there is media coverage for trial alpha or there is investor interest in trial alpha."
      },
      {
        "id": "Rule13",
        "formal": "(A31 → (A29 ∨ (¬(A9 → A10) → A28)))",
        "prover9_expression": "(investor_interest(trial_alpha) -> (conference_presentation(trial_alpha) | (-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> publication_pending(trial_alpha))))",
        "natural": "Provided there is investor interest in trial alpha, either a conference presentation was made for trial alpha, or if Dr. Smith is not certified as a researcher implying the protocol was followed in trial alpha, then a publication is pending for trial alpha."
      },
      {
        "id": "Rule14",
        "formal": "(A4 ∨ A5)",
        "prover9_expression": "(safety_established(trial_alpha) | efficacy_established(trial_alpha))",
        "natural": "Either safety has been established for trial alpha or efficacy has been established for trial alpha."
      },
      {
        "id": "Rule15",
        "formal": "(A5 → A3)",
        "prover9_expression": "(efficacy_established(trial_alpha) -> phase2_complete(trial_alpha))",
        "natural": "Assuming efficacy has been established for trial alpha, phase 2 of trial alpha is complete."
      },
      {
        "id": "Rule16",
        "formal": "(A6 → A16)",
        "prover9_expression": "(trial_terminated(trial_alpha) -> analysis_complete(trial_alpha))",
        "natural": "Provided that trial alpha has been terminated, analysis is complete for trial alpha."
      },
      {
        "id": "Rule17",
        "formal": "(A6 → ¬A14)",
        "prover9_expression": "(trial_terminated(trial_alpha) -> -patient_recruitment(trial_alpha))",
        "natural": "Should trial alpha be terminated, it is not the case that patient recruitment is complete for trial alpha."
      },
      {
        "id": "Rule18",
        "formal": "(A6 ∨ (A4 → A2))",
        "prover9_expression": "(trial_terminated(trial_alpha) | (safety_established(trial_alpha) -> phase1_complete(trial_alpha)))",
        "natural": "Either trial alpha has been terminated, or if safety has been established for trial alpha, then phase 1 of trial alpha is complete."
      },
      {
        "id": "Rule19",
        "formal": "(A7 → ¬A6)",
        "prover9_expression": "(adverse_events(trial_alpha) -> -trial_terminated(trial_alpha))",
        "natural": "Whenever adverse events occurred in trial alpha, trial alpha is not terminated."
      },
      {
        "id": "Rule20",
        "formal": "(A7 ∨ A8)",
        "prover9_expression": "(adverse_events(trial_alpha) | funding_withdrawn(trial_alpha))",
        "natural": "Either adverse events occurred in trial alpha or funding was withdrawn from trial alpha."
      },
      {
        "id": "Rule21",
        "formal": "(A8 → ¬A6)",
        "prover9_expression": "(funding_withdrawn(trial_alpha) -> -trial_terminated(trial_alpha))",
        "natural": "Assuming funding was withdrawn from trial alpha, trial alpha is not terminated."
      },
      {
        "id": "Rule22",
        "formal": "(A9 → ¬A10)",
        "prover9_expression": "(researcher_certified(dr_smith) -> -protocol_followed(trial_alpha))",
        "natural": "Should Dr. Smith be certified as a researcher, it is not the case that the protocol was followed in trial alpha."
      },
      {
        "id": "Rule23",
        "formal": "(¬(A2 ∨ A3) → A19)",
        "prover9_expression": "(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> protocol_modified(trial_alpha))",
        "natural": "Whenever it is not the case that either phase 1 of trial alpha is complete or phase 2 of trial alpha is complete, the protocol was modified for trial alpha."
      },
      {
        "id": "Rule24",
        "formal": "(¬(A9 → A10) → A11)",
        "prover9_expression": "(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> data_valid(trial_alpha))",
        "natural": "If it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is valid."
      },
      {
        "id": "Rule25",
        "formal": "(¬(A9 → A22) → A23)",
        "prover9_expression": "(-(researcher_certified(dr_smith) -> monitoring_complete(trial_alpha)) -> data_audit(trial_alpha))",
        "natural": "Should it not be the case that Dr. Smith is certified as a researcher implying monitoring is complete for trial alpha, then a data audit was conducted for trial alpha."
      },
      {
        "id": "Rule26",
        "formal": "(¬(A9 → A22) → A24)",
        "prover9_expression": "(-(researcher_certified(dr_smith) -> monitoring_complete(trial_alpha)) -> audit_clean(trial_alpha))",
        "natural": "If it is not the case that Dr. Smith is certified as a researcher implying monitoring is complete for trial alpha, then the audit for trial alpha is clean."
      },
      {
        "id": "Rule27",
        "formal": "(¬(¬(A2 ∨ A3) → A17) → A18)",
        "prover9_expression": "(-(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> trial_extended(trial_alpha)) -> additional_funding(trial_alpha))",
        "natural": "Whenever it is not the case that if neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then trial alpha has been extended, additional funding has been provided for trial alpha."
      },
      {
        "id": "Rule28",
        "formal": "(¬(¬(A2 ∨ A3) → A17) → ¬A18)",
        "prover9_expression": "(-(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> trial_extended(trial_alpha)) -> -additional_funding(trial_alpha))",
        "natural": "Should it not be the case that if neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then trial alpha has been extended, it is not the case that additional funding has been provided for trial alpha."
      },
      {
        "id": "Rule29",
        "formal": "(¬(¬(A2 ∨ A3) → ¬A19) → A20)",
        "prover9_expression": "(-(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> -protocol_modified(trial_alpha)) -> new_endpoints(trial_alpha))",
        "natural": "Assuming it is not the case that if neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then it is not the case that the protocol was modified for trial alpha, new endpoints were established for trial alpha."
      },
      {
        "id": "Rule30",
        "formal": "(¬(¬(A2 ∨ A3) → ¬A19) → ¬A20)",
        "prover9_expression": "(-(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> -protocol_modified(trial_alpha)) -> -new_endpoints(trial_alpha))",
        "natural": "In the event that it is not the case that if neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then it is not the case that the protocol was modified for trial alpha, it is not the case that new endpoints were established for trial alpha."
      },
      {
        "id": "Rule31",
        "formal": "(¬(¬(A9 → A10) → ¬A11) → A12)",
        "prover9_expression": "(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> regulatory_approval(trial_alpha))",
        "natural": "Provided that it is not the case that if it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is not valid, regulatory approval has been granted for trial alpha."
      },
      {
        "id": "Rule32",
        "formal": "(¬(¬(A9 → A10) → ¬A11) → A13)",
        "prover9_expression": "(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> fast_track_status(trial_alpha))",
        "natural": "If it is not the case that if it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is not valid, trial alpha has fast-track status."
      },
      {
        "id": "Rule33",
        "formal": "(¬(¬(¬(A9 → A10) → ¬A11) → A25) → ¬A26)",
        "prover9_expression": "(-(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> market_approval(drug_x)) -> -patent_filed(drug_x))",
        "natural": "In the event that it is not the case that if it is not the case that whenever Dr. Smith is certified as a researcher, the protocol was followed in trial alpha, and this leads to the data from trial alpha not being valid, then market approval for drug X results, it is not the case that a patent has been filed for drug X."
      },
      {
        "id": "Rule34",
        "formal": "(¬G → A1)",
        "prover9_expression": "(-fda_oversight(trial_alpha) -> approved(drug_x))",
        "natural": "If there is no FDA oversight for trial alpha, then drug X is approved."
      },
      {
        "id": "Rule35",
        "formal": "(¬G → A9)",
        "prover9_expression": "(-fda_oversight(trial_alpha) -> researcher_certified(dr_smith))",
        "natural": "Provided there is no FDA oversight for trial alpha, Dr. Smith is certified as a researcher."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "¬A17",
        "prover9_expression": "-trial_extended(trial_alpha)",
        "natural": "It is not the case that trial alpha has been extended."
      },
      {
        "id": "Fact2",
        "formal": "¬A21",
        "prover9_expression": "-gcp_trained(dr_smith)",
        "natural": "It is not the case that Dr. Smith is trained in Good Clinical Practice."
      },
      {
        "id": "Fact3",
        "formal": "¬A27",
        "prover9_expression": "-competitor_advantage(drug_y)",
        "natural": "It is not the case that competitor drug Y has an advantage."
      },
      {
        "id": "Fact4",
        "formal": "¬A29",
        "prover9_expression": "-conference_presentation(trial_alpha)",
        "natural": "It is not the case that a conference presentation was made for trial alpha."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "fda_oversight(trial_alpha)",
    "natural": "There is FDA oversight for trial alpha."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A7 | A8)",
            "(A7 -> -A6)",
            "(A8 -> -A6)"
          ],
          "conclusion": "-A6",
          "natural": "It is not the case that trial alpha has been terminated."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A6 | (A4 -> A2))",
            "-A6"
          ],
          "conclusion": "(A4 -> A2)",
          "natural": "If safety has been established for trial alpha, then phase 1 of trial alpha is complete."
        },
        {
          "step_number": 3,
          "rule_applied": "CD",
          "premises_used": [
            "(A4 -> A2)",
            "(A5 -> A3)",
            "(A4 | A5)"
          ],
          "conclusion": "(A2 | A3)",
          "natural": "Either phase 1 of trial alpha is complete or phase 2 of trial alpha is complete."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A2 | A3)",
            "(A2 -> (-G -> -A1))",
            "(A3 -> (-G -> -A1))"
          ],
          "conclusion": "(-G -> -A1)",
          "natural": "Should there be no FDA oversight for trial alpha, drug X is not approved."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A1)",
            "(-G -> -A1)"
          ],
          "conclusion": "G",
          "natural": "There is FDA oversight for trial alpha."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(A9 -> A10) -> -A11) -> A13)",
            "(A13 -> -A12)"
          ],
          "conclusion": "(-(-(A9 -> A10) -> -A11) -> -A12)",
          "natural": "Whenever it is not the case that if it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is not valid, it is not the case that regulatory approval has been granted for trial alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(A9 -> A10) -> -A11) -> A12)",
            "(-(-(A9 -> A10) -> -A11) -> -A12)"
          ],
          "conclusion": "(-(A9 -> A10) -> -A11)",
          "natural": "In the event that it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, the data from trial alpha is not valid."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A9 -> A10) -> A11)",
            "(-(A9 -> A10) -> -A11)"
          ],
          "conclusion": "(A9 -> A10)",
          "natural": "If Dr. Smith is certified as a researcher, then the protocol was followed in trial alpha."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(A9 -> A10)",
            "(A9 -> -A10)"
          ],
          "conclusion": "-A9",
          "natural": "It is not the case that Dr. Smith is certified as a researcher."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A9)",
            "-A9"
          ],
          "conclusion": "G",
          "natural": "There is FDA oversight for trial alpha."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A6 -> A16)",
            "(A16 -> A15)"
          ],
          "conclusion": "(A6 -> A15)",
          "natural": "If trial alpha has been terminated, then dosing is complete for trial alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A6 -> A15)",
            "(A15 -> A14)"
          ],
          "conclusion": "(A6 -> A14)",
          "natural": "In the event that trial alpha has been terminated, patient recruitment for trial alpha has occurred."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(A6 -> A14)",
            "(A6 -> -A14)"
          ],
          "conclusion": "-A6",
          "natural": "It is not the case that trial alpha has been terminated."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A6 | (A4 -> A2))",
            "-A6"
          ],
          "conclusion": "(A4 -> A2)",
          "natural": "If safety has been established for trial alpha, then phase 1 of trial alpha is complete."
        },
        {
          "step_number": 5,
          "rule_applied": "CD",
          "premises_used": [
            "(A4 -> A2)",
            "(A5 -> A3)",
            "(A4 | A5)"
          ],
          "conclusion": "(A2 | A3)",
          "natural": "Either phase 1 of trial alpha is complete or phase 2 of trial alpha is complete."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A2 | A3)",
            "(A2 -> (-G -> -A1))",
            "(A3 -> (-G -> -A1))"
          ],
          "conclusion": "(-G -> -A1)",
          "natural": "Should there be no FDA oversight for trial alpha, drug X is not approved."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A1)",
            "(-G -> -A1)"
          ],
          "conclusion": "G",
          "natural": "There is FDA oversight for trial alpha."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(A2 | A3) -> A17) -> A18)",
            "(-(-(A2 | A3) -> A17) -> -A18)"
          ],
          "conclusion": "(-(A2 | A3) -> A17)",
          "natural": "If neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then trial alpha has been extended."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A2 | A3) -> A17)",
            "-A17"
          ],
          "conclusion": "(A2 | A3)",
          "natural": "Either phase 1 of trial alpha is complete or phase 2 of trial alpha is complete."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            "(A2 | A3)",
            "(A2 -> (-G -> -A1))",
            "(A3 -> (-G -> -A1))"
          ],
          "conclusion": "(-G -> -A1)",
          "natural": "Should there be no FDA oversight for trial alpha, drug X is not approved."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A1)",
            "(-G -> -A1)"
          ],
          "conclusion": "G",
          "natural": "There is FDA oversight for trial alpha."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(A2 | A3) -> -A19) -> A20)",
            "(-(-(A2 | A3) -> -A19) -> -A20)"
          ],
          "conclusion": "(-(A2 | A3) -> -A19)",
          "natural": "Provided that neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, it is not the case that the protocol was modified for trial alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A2 | A3) -> A19)",
            "(-(A2 | A3) -> -A19)"
          ],
          "conclusion": "(A2 | A3)",
          "natural": "Either phase 1 of trial alpha is complete or phase 2 of trial alpha is complete."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            "(A2 | A3)",
            "(A2 -> (-G -> -A1))",
            "(A3 -> (-G -> -A1))"
          ],
          "conclusion": "(-G -> -A1)",
          "natural": "Should there be no FDA oversight for trial alpha, drug X is not approved."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A1)",
            "(-G -> -A1)"
          ],
          "conclusion": "G",
          "natural": "There is FDA oversight for trial alpha."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A9 -> A22) -> A24)",
            "(A24 -> -A23)"
          ],
          "conclusion": "(-(A9 -> A22) -> -A23)",
          "natural": "Provided that it is not the case that Dr. Smith is certified as a researcher implying monitoring is complete for trial alpha, it is not the case that a data audit was conducted for trial alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A9 -> A22) -> A23)",
            "(-(A9 -> A22) -> -A23)"
          ],
          "conclusion": "(A9 -> A22)",
          "natural": "In the event that Dr. Smith is certified as a researcher, monitoring is complete for trial alpha."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(A9 -> A22)",
            "(A22 -> A21)"
          ],
          "conclusion": "(A9 -> A21)",
          "natural": "Provided that Dr. Smith is certified as a researcher, Dr. Smith is trained in Good Clinical Practice."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(A9 -> A21)",
            "-A21"
          ],
          "conclusion": "-A9",
          "natural": "It is not the case that Dr. Smith is certified as a researcher."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A9)",
            "-A9"
          ],
          "conclusion": "G",
          "natural": "There is FDA oversight for trial alpha."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A27 | (-(-(-(A9 -> A10) -> -A11) -> A25) -> A26))",
            "-A27"
          ],
          "conclusion": "(-(-(-(A9 -> A10) -> -A11) -> A25) -> A26)",
          "natural": "Assuming it is not the case that if it is not the case that whenever Dr. Smith is certified as a researcher, the protocol was followed in trial alpha, and this leads to the data from trial alpha not being valid, then market approval for drug X results, a patent has been filed for drug X."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(-(A9 -> A10) -> -A11) -> A25) -> A26)",
            "(-(-(-(A9 -> A10) -> -A11) -> A25) -> -A26)"
          ],
          "conclusion": "(-(-(A9 -> A10) -> -A11) -> A25)",
          "natural": "Should it not be the case that if it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is not valid, market approval has been granted for drug X."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(A9 -> A10) -> -A11) -> A25)",
            "(A25 -> -A12)"
          ],
          "conclusion": "(-(-(A9 -> A10) -> -A11) -> -A12)",
          "natural": "Whenever it is not the case that if it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is not valid, it is not the case that regulatory approval has been granted for trial alpha."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(A9 -> A10) -> -A11) -> A12)",
            "(-(-(A9 -> A10) -> -A11) -> -A12)"
          ],
          "conclusion": "(-(A9 -> A10) -> -A11)",
          "natural": "In the event that it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, the data from trial alpha is not valid."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A9 -> A10) -> A11)",
            "(-(A9 -> A10) -> -A11)"
          ],
          "conclusion": "(A9 -> A10)",
          "natural": "If Dr. Smith is certified as a researcher, then the protocol was followed in trial alpha."
        },
        {
          "step_number": 6,
          "rule_applied": "RAA",
          "premises_used": [
            "(A9 -> A10)",
            "(A9 -> -A10)"
          ],
          "conclusion": "-A9",
          "natural": "It is not the case that Dr. Smith is certified as a researcher."
        },
        {
          "step_number": 7,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A9)",
            "-A9"
          ],
          "conclusion": "G",
          "natural": "There is FDA oversight for trial alpha."
        }
      ]
    },
    {
      "id": 8,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A30 | A31)",
            "(A30 -> (A29 | (-(A9 -> A10) -> A28)))",
            "(A31 -> (A29 | (-(A9 -> A10) -> A28)))"
          ],
          "conclusion": "(A29 | (-(A9 -> A10) -> A28))",
          "natural": "Either a conference presentation was made for trial alpha, or if Dr. Smith is not certified as a researcher implying the protocol was followed in trial alpha, then a publication is pending for trial alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A29 | (-(A9 -> A10) -> A28))",
            "-A29"
          ],
          "conclusion": "(-(A9 -> A10) -> A28)",
          "natural": "Assuming it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, a publication is pending for trial alpha."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A9 -> A10) -> A28)",
            "(A28 -> -A11)"
          ],
          "conclusion": "(-(A9 -> A10) -> -A11)",
          "natural": "In the event that it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, the data from trial alpha is not valid."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A9 -> A10) -> A11)",
            "(-(A9 -> A10) -> -A11)"
          ],
          "conclusion": "(A9 -> A10)",
          "natural": "If Dr. Smith is certified as a researcher, then the protocol was followed in trial alpha."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(A9 -> A10)",
            "(A9 -> -A10)"
          ],
          "conclusion": "-A9",
          "natural": "It is not the case that Dr. Smith is certified as a researcher."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A9)",
            "-A9"
          ],
          "conclusion": "G",
          "natural": "There is FDA oversight for trial alpha."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Pharmaceutical Clinical Trial",
    "atomic_facts": {
      "A1": "approved(drug_x)",
      "A2": "phase1_complete(trial_alpha)",
      "A3": "phase2_complete(trial_alpha)",
      "A4": "safety_established(trial_alpha)",
      "A5": "efficacy_established(trial_alpha)",
      "A6": "trial_terminated(trial_alpha)",
      "A7": "adverse_events(trial_alpha)",
      "A8": "funding_withdrawn(trial_alpha)",
      "A9": "researcher_certified(dr_smith)",
      "A10": "protocol_followed(trial_alpha)",
      "A11": "data_valid(trial_alpha)",
      "A12": "regulatory_approval(trial_alpha)",
      "A13": "fast_track_status(trial_alpha)",
      "A14": "patient_recruitment(trial_alpha)",
      "A15": "dosing_complete(trial_alpha)",
      "A16": "analysis_complete(trial_alpha)",
      "A17": "trial_extended(trial_alpha)",
      "A18": "additional_funding(trial_alpha)",
      "A19": "protocol_modified(trial_alpha)",
      "A20": "new_endpoints(trial_alpha)",
      "A21": "gcp_trained(dr_smith)",
      "A22": "monitoring_complete(trial_alpha)",
      "A23": "data_audit(trial_alpha)",
      "A24": "audit_clean(trial_alpha)",
      "A25": "market_approval(drug_x)",
      "A26": "patent_filed(drug_x)",
      "A27": "competitor_advantage(drug_y)",
      "A28": "publication_pending(trial_alpha)",
      "A29": "conference_presentation(trial_alpha)",
      "A30": "media_coverage(trial_alpha)",
      "A31": "investor_interest(trial_alpha)",
      "G": "fda_oversight(trial_alpha)"
    },
    "natural_facts": {
      "A1": "Drug X is approved.",
      "A2": "Phase 1 of trial alpha is complete.",
      "A3": "Phase 2 of trial alpha is complete.",
      "A4": "Safety has been established for trial alpha.",
      "A5": "Efficacy has been established for trial alpha.",
      "A6": "Trial alpha has been terminated.",
      "A7": "Adverse events occurred in trial alpha.",
      "A8": "Funding was withdrawn from trial alpha.",
      "A9": "Dr. Smith is certified as a researcher.",
      "A10": "The protocol was followed in trial alpha.",
      "A11": "The data from trial alpha is valid.",
      "A12": "Regulatory approval has been granted for trial alpha.",
      "A13": "Trial alpha has fast-track status.",
      "A14": "Patient recruitment is complete for trial alpha.",
      "A15": "Dosing is complete for trial alpha.",
      "A16": "Analysis is complete for trial alpha.",
      "A17": "Trial alpha has been extended.",
      "A18": "Additional funding has been provided for trial alpha.",
      "A19": "The protocol was modified for trial alpha.",
      "A20": "New endpoints were established for trial alpha.",
      "A21": "Dr. Smith is trained in Good Clinical Practice.",
      "A22": "Monitoring is complete for trial alpha.",
      "A23": "A data audit was conducted for trial alpha.",
      "A24": "The audit for trial alpha is clean.",
      "A25": "Market approval has been granted for drug X.",
      "A26": "A patent has been filed for drug X.",
      "A27": "Competitor drug Y has an advantage.",
      "A28": "A publication is pending for trial alpha.",
      "A29": "A conference presentation was made for trial alpha.",
      "A30": "There is media coverage for trial alpha.",
      "A31": "There is investor interest in trial alpha.",
      "G": "There is FDA oversight for trial alpha."
    },
    "prover9_expressions": [
      "(fast_track_status(trial_alpha) -> -regulatory_approval(trial_alpha))",
      "(dosing_complete(trial_alpha) -> patient_recruitment(trial_alpha))",
      "(analysis_complete(trial_alpha) -> dosing_complete(trial_alpha))",
      "(phase1_complete(trial_alpha) -> (-fda_oversight(trial_alpha) -> -approved(drug_x)))",
      "(phase1_complete(trial_alpha) | phase2_complete(trial_alpha))",
      "(monitoring_complete(trial_alpha) -> gcp_trained(dr_smith))",
      "(audit_clean(trial_alpha) -> -data_audit(trial_alpha))",
      "(market_approval(drug_x) -> -regulatory_approval(trial_alpha))",
      "(competitor_advantage(drug_y) | (-(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> market_approval(drug_x)) -> patent_filed(drug_x)))",
      "(publication_pending(trial_alpha) -> -data_valid(trial_alpha))",
      "(conference_presentation(trial_alpha) | (-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> publication_pending(trial_alpha)))",
      "(phase2_complete(trial_alpha) -> (-fda_oversight(trial_alpha) -> -approved(drug_x)))",
      "(media_coverage(trial_alpha) -> (conference_presentation(trial_alpha) | (-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> publication_pending(trial_alpha))))",
      "(media_coverage(trial_alpha) | investor_interest(trial_alpha))",
      "(investor_interest(trial_alpha) -> (conference_presentation(trial_alpha) | (-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> publication_pending(trial_alpha))))",
      "(safety_established(trial_alpha) -> phase1_complete(trial_alpha))",
      "(safety_established(trial_alpha) | efficacy_established(trial_alpha))",
      "(efficacy_established(trial_alpha) -> phase2_complete(trial_alpha))",
      "(trial_terminated(trial_alpha) -> patient_recruitment(trial_alpha))",
      "(trial_terminated(trial_alpha) -> dosing_complete(trial_alpha))",
      "(trial_terminated(trial_alpha) -> analysis_complete(trial_alpha))",
      "(trial_terminated(trial_alpha) -> -patient_recruitment(trial_alpha))",
      "(trial_terminated(trial_alpha) | (safety_established(trial_alpha) -> phase1_complete(trial_alpha)))",
      "(adverse_events(trial_alpha) -> -trial_terminated(trial_alpha))",
      "(adverse_events(trial_alpha) | funding_withdrawn(trial_alpha))",
      "(funding_withdrawn(trial_alpha) -> -trial_terminated(trial_alpha))",
      "(researcher_certified(dr_smith) -> protocol_followed(trial_alpha))",
      "(researcher_certified(dr_smith) -> gcp_trained(dr_smith))",
      "(researcher_certified(dr_smith) -> monitoring_complete(trial_alpha))",
      "(researcher_certified(dr_smith) -> -protocol_followed(trial_alpha))",
      "(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> trial_extended(trial_alpha))",
      "(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> protocol_modified(trial_alpha))",
      "(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> -protocol_modified(trial_alpha))",
      "(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> data_valid(trial_alpha))",
      "(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> publication_pending(trial_alpha))",
      "(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha))",
      "(-(researcher_certified(dr_smith) -> monitoring_complete(trial_alpha)) -> data_audit(trial_alpha))",
      "(-(researcher_certified(dr_smith) -> monitoring_complete(trial_alpha)) -> audit_clean(trial_alpha))",
      "(-(researcher_certified(dr_smith) -> monitoring_complete(trial_alpha)) -> -data_audit(trial_alpha))",
      "(-(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> trial_extended(trial_alpha)) -> additional_funding(trial_alpha))",
      "(-(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> trial_extended(trial_alpha)) -> -additional_funding(trial_alpha))",
      "(-(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> -protocol_modified(trial_alpha)) -> new_endpoints(trial_alpha))",
      "(-(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> -protocol_modified(trial_alpha)) -> -new_endpoints(trial_alpha))",
      "(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> regulatory_approval(trial_alpha))",
      "(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> fast_track_status(trial_alpha))",
      "(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> market_approval(drug_x))",
      "(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> -regulatory_approval(trial_alpha))",
      "(-(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> market_approval(drug_x)) -> patent_filed(drug_x))",
      "(-(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> market_approval(drug_x)) -> -patent_filed(drug_x))",
      "(-fda_oversight(trial_alpha) -> approved(drug_x))",
      "(-fda_oversight(trial_alpha) -> researcher_certified(dr_smith))",
      "(-fda_oversight(trial_alpha) -> -approved(drug_x))",
      "fda_oversight(trial_alpha)",
      "-trial_extended(trial_alpha)",
      "-gcp_trained(dr_smith)",
      "-competitor_advantage(drug_y)",
      "-conference_presentation(trial_alpha)",
      "-trial_terminated(trial_alpha)",
      "-researcher_certified(dr_smith)"
    ],
    "natural_expressions": [
      "If trial alpha has fast-track status, then regulatory approval for trial alpha is not granted.",
      "Provided that dosing is complete for trial alpha, patient recruitment for trial alpha has occurred.",
      "Whenever analysis is complete for trial alpha, dosing for trial alpha is complete.",
      "If phase 1 of trial alpha is complete, then in the absence of FDA oversight for trial alpha, drug X is not approved.",
      "Either phase 1 of trial alpha is complete or phase 2 of trial alpha is complete.",
      "Assuming monitoring is complete for trial alpha, Dr. Smith is trained in Good Clinical Practice.",
      "If the audit for trial alpha is clean, then it is not the case that a data audit was conducted for trial alpha.",
      "In the event that market approval is granted for drug X, regulatory approval for trial alpha is not granted.",
      "Either competitor drug Y has an advantage, or if it is not the case that whenever Dr. Smith is certified as a researcher, the protocol was followed in trial alpha, and this leads to the data from trial alpha not being valid, then market approval for drug X results in a patent being filed for drug X.",
      "Should a publication be pending for trial alpha, the data from trial alpha is not valid.",
      "Either a conference presentation was made for trial alpha, or if Dr. Smith is not certified as a researcher implying the protocol was followed in trial alpha, then a publication is pending for trial alpha.",
      "If phase 2 of trial alpha is complete, then given that there is no FDA oversight for trial alpha, drug X is not approved.",
      "Whenever there is media coverage for trial alpha, either a conference presentation was made for trial alpha, or if Dr. Smith is not certified as a researcher implying the protocol was followed in trial alpha, then a publication is pending for trial alpha.",
      "Either there is media coverage for trial alpha or there is investor interest in trial alpha.",
      "Provided there is investor interest in trial alpha, either a conference presentation was made for trial alpha, or if Dr. Smith is not certified as a researcher implying the protocol was followed in trial alpha, then a publication is pending for trial alpha.",
      "If safety has been established for trial alpha, then phase 1 of trial alpha is complete.",
      "Either safety has been established for trial alpha or efficacy has been established for trial alpha.",
      "Assuming efficacy has been established for trial alpha, phase 2 of trial alpha is complete.",
      "In the event that trial alpha has been terminated, patient recruitment for trial alpha has occurred.",
      "If trial alpha has been terminated, then dosing is complete for trial alpha.",
      "Provided that trial alpha has been terminated, analysis is complete for trial alpha.",
      "Should trial alpha be terminated, it is not the case that patient recruitment is complete for trial alpha.",
      "Either trial alpha has been terminated, or if safety has been established for trial alpha, then phase 1 of trial alpha is complete.",
      "Whenever adverse events occurred in trial alpha, trial alpha is not terminated.",
      "Either adverse events occurred in trial alpha or funding was withdrawn from trial alpha.",
      "Assuming funding was withdrawn from trial alpha, trial alpha is not terminated.",
      "If Dr. Smith is certified as a researcher, then the protocol was followed in trial alpha.",
      "Provided that Dr. Smith is certified as a researcher, Dr. Smith is trained in Good Clinical Practice.",
      "In the event that Dr. Smith is certified as a researcher, monitoring is complete for trial alpha.",
      "Should Dr. Smith be certified as a researcher, it is not the case that the protocol was followed in trial alpha.",
      "If neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then trial alpha has been extended.",
      "Whenever it is not the case that either phase 1 of trial alpha is complete or phase 2 of trial alpha is complete, the protocol was modified for trial alpha.",
      "Provided that neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, it is not the case that the protocol was modified for trial alpha.",
      "If it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is valid.",
      "Assuming it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, a publication is pending for trial alpha.",
      "In the event that it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, the data from trial alpha is not valid.",
      "Should it not be the case that Dr. Smith is certified as a researcher implying monitoring is complete for trial alpha, then a data audit was conducted for trial alpha.",
      "If it is not the case that Dr. Smith is certified as a researcher implying monitoring is complete for trial alpha, then the audit for trial alpha is clean.",
      "Provided that it is not the case that Dr. Smith is certified as a researcher implying monitoring is complete for trial alpha, it is not the case that a data audit was conducted for trial alpha.",
      "Whenever it is not the case that if neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then trial alpha has been extended, additional funding has been provided for trial alpha.",
      "Should it not be the case that if neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then trial alpha has been extended, it is not the case that additional funding has been provided for trial alpha.",
      "Assuming it is not the case that if neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then it is not the case that the protocol was modified for trial alpha, new endpoints were established for trial alpha.",
      "In the event that it is not the case that if neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then it is not the case that the protocol was modified for trial alpha, it is not the case that new endpoints were established for trial alpha.",
      "Provided that it is not the case that if it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is not valid, regulatory approval has been granted for trial alpha.",
      "If it is not the case that if it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is not valid, trial alpha has fast-track status.",
      "Should it not be the case that if it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is not valid, market approval has been granted for drug X.",
      "Whenever it is not the case that if it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is not valid, it is not the case that regulatory approval has been granted for trial alpha.",
      "Assuming it is not the case that if it is not the case that whenever Dr. Smith is certified as a researcher, the protocol was followed in trial alpha, and this leads to the data from trial alpha not being valid, then market approval for drug X results, a patent has been filed for drug X.",
      "In the event that it is not the case that if it is not the case that whenever Dr. Smith is certified as a researcher, the protocol was followed in trial alpha, and this leads to the data from trial alpha not being valid, then market approval for drug X results, it is not the case that a patent has been filed for drug X.",
      "If there is no FDA oversight for trial alpha, then drug X is approved.",
      "Provided there is no FDA oversight for trial alpha, Dr. Smith is certified as a researcher.",
      "Should there be no FDA oversight for trial alpha, drug X is not approved.",
      "There is FDA oversight for trial alpha.",
      "It is not the case that trial alpha has been extended.",
      "It is not the case that Dr. Smith is trained in Good Clinical Practice.",
      "It is not the case that competitor drug Y has an advantage.",
      "It is not the case that a conference presentation was made for trial alpha.",
      "It is not the case that trial alpha has been terminated.",
      "It is not the case that Dr. Smith is certified as a researcher."
    ],
    "node_mappings": {
      "(A13 → ¬A12)": {
        "formal": "(A13 → ¬A12)",
        "prover9": "(A13 -> -A12)",
        "prover9_expression": "(fast_track_status(trial_alpha) -> -regulatory_approval(trial_alpha))",
        "natural": "If trial alpha has fast-track status, then regulatory approval for trial alpha is not granted."
      },
      "(A15 → A14)": {
        "formal": "(A15 → A14)",
        "prover9": "(A15 -> A14)",
        "prover9_expression": "(dosing_complete(trial_alpha) -> patient_recruitment(trial_alpha))",
        "natural": "Provided that dosing is complete for trial alpha, patient recruitment for trial alpha has occurred."
      },
      "(A16 → A15)": {
        "formal": "(A16 → A15)",
        "prover9": "(A16 -> A15)",
        "prover9_expression": "(analysis_complete(trial_alpha) -> dosing_complete(trial_alpha))",
        "natural": "Whenever analysis is complete for trial alpha, dosing for trial alpha is complete."
      },
      "(A2 → (¬G → ¬A1))": {
        "formal": "(A2 → (¬G → ¬A1))",
        "prover9": "(A2 -> (-G -> -A1))",
        "prover9_expression": "(phase1_complete(trial_alpha) -> (-fda_oversight(trial_alpha) -> -approved(drug_x)))",
        "natural": "If phase 1 of trial alpha is complete, then in the absence of FDA oversight for trial alpha, drug X is not approved."
      },
      "(A2 ∨ A3)": {
        "formal": "(A2 ∨ A3)",
        "prover9": "(A2 | A3)",
        "prover9_expression": "(phase1_complete(trial_alpha) | phase2_complete(trial_alpha))",
        "natural": "Either phase 1 of trial alpha is complete or phase 2 of trial alpha is complete."
      },
      "(A22 → A21)": {
        "formal": "(A22 → A21)",
        "prover9": "(A22 -> A21)",
        "prover9_expression": "(monitoring_complete(trial_alpha) -> gcp_trained(dr_smith))",
        "natural": "Assuming monitoring is complete for trial alpha, Dr. Smith is trained in Good Clinical Practice."
      },
      "(A24 → ¬A23)": {
        "formal": "(A24 → ¬A23)",
        "prover9": "(A24 -> -A23)",
        "prover9_expression": "(audit_clean(trial_alpha) -> -data_audit(trial_alpha))",
        "natural": "If the audit for trial alpha is clean, then it is not the case that a data audit was conducted for trial alpha."
      },
      "(A25 → ¬A12)": {
        "formal": "(A25 → ¬A12)",
        "prover9": "(A25 -> -A12)",
        "prover9_expression": "(market_approval(drug_x) -> -regulatory_approval(trial_alpha))",
        "natural": "In the event that market approval is granted for drug X, regulatory approval for trial alpha is not granted."
      },
      "(A27 ∨ (¬(¬(¬(A9 → A10) → ¬A11) → A25) → A26))": {
        "formal": "(A27 ∨ (¬(¬(¬(A9 → A10) → ¬A11) → A25) → A26))",
        "prover9": "(A27 | (-(-(-(A9 -> A10) -> -A11) -> A25) -> A26))",
        "prover9_expression": "(competitor_advantage(drug_y) | (-(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> market_approval(drug_x)) -> patent_filed(drug_x)))",
        "natural": "Either competitor drug Y has an advantage, or if it is not the case that whenever Dr. Smith is certified as a researcher, the protocol was followed in trial alpha, and this leads to the data from trial alpha not being valid, then market approval for drug X results in a patent being filed for drug X."
      },
      "(A28 → ¬A11)": {
        "formal": "(A28 → ¬A11)",
        "prover9": "(A28 -> -A11)",
        "prover9_expression": "(publication_pending(trial_alpha) -> -data_valid(trial_alpha))",
        "natural": "Should a publication be pending for trial alpha, the data from trial alpha is not valid."
      },
      "(A29 ∨ (¬(A9 → A10) → A28))": {
        "formal": "(A29 ∨ (¬(A9 → A10) → A28))",
        "prover9": "(A29 | (-(A9 -> A10) -> A28))",
        "prover9_expression": "(conference_presentation(trial_alpha) | (-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> publication_pending(trial_alpha)))",
        "natural": "Either a conference presentation was made for trial alpha, or if Dr. Smith is not certified as a researcher implying the protocol was followed in trial alpha, then a publication is pending for trial alpha."
      },
      "(A3 → (¬G → ¬A1))": {
        "formal": "(A3 → (¬G → ¬A1))",
        "prover9": "(A3 -> (-G -> -A1))",
        "prover9_expression": "(phase2_complete(trial_alpha) -> (-fda_oversight(trial_alpha) -> -approved(drug_x)))",
        "natural": "If phase 2 of trial alpha is complete, then given that there is no FDA oversight for trial alpha, drug X is not approved."
      },
      "(A30 → (A29 ∨ (¬(A9 → A10) → A28)))": {
        "formal": "(A30 → (A29 ∨ (¬(A9 → A10) → A28)))",
        "prover9": "(A30 -> (A29 | (-(A9 -> A10) -> A28)))",
        "prover9_expression": "(media_coverage(trial_alpha) -> (conference_presentation(trial_alpha) | (-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> publication_pending(trial_alpha))))",
        "natural": "Whenever there is media coverage for trial alpha, either a conference presentation was made for trial alpha, or if Dr. Smith is not certified as a researcher implying the protocol was followed in trial alpha, then a publication is pending for trial alpha."
      },
      "(A30 ∨ A31)": {
        "formal": "(A30 ∨ A31)",
        "prover9": "(A30 | A31)",
        "prover9_expression": "(media_coverage(trial_alpha) | investor_interest(trial_alpha))",
        "natural": "Either there is media coverage for trial alpha or there is investor interest in trial alpha."
      },
      "(A31 → (A29 ∨ (¬(A9 → A10) → A28)))": {
        "formal": "(A31 → (A29 ∨ (¬(A9 → A10) → A28)))",
        "prover9": "(A31 -> (A29 | (-(A9 -> A10) -> A28)))",
        "prover9_expression": "(investor_interest(trial_alpha) -> (conference_presentation(trial_alpha) | (-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> publication_pending(trial_alpha))))",
        "natural": "Provided there is investor interest in trial alpha, either a conference presentation was made for trial alpha, or if Dr. Smith is not certified as a researcher implying the protocol was followed in trial alpha, then a publication is pending for trial alpha."
      },
      "(A4 → A2)": {
        "formal": "(A4 → A2)",
        "prover9": "(A4 -> A2)",
        "prover9_expression": "(safety_established(trial_alpha) -> phase1_complete(trial_alpha))",
        "natural": "If safety has been established for trial alpha, then phase 1 of trial alpha is complete."
      },
      "(A4 ∨ A5)": {
        "formal": "(A4 ∨ A5)",
        "prover9": "(A4 | A5)",
        "prover9_expression": "(safety_established(trial_alpha) | efficacy_established(trial_alpha))",
        "natural": "Either safety has been established for trial alpha or efficacy has been established for trial alpha."
      },
      "(A5 → A3)": {
        "formal": "(A5 → A3)",
        "prover9": "(A5 -> A3)",
        "prover9_expression": "(efficacy_established(trial_alpha) -> phase2_complete(trial_alpha))",
        "natural": "Assuming efficacy has been established for trial alpha, phase 2 of trial alpha is complete."
      },
      "(A6 → A14)": {
        "formal": "(A6 → A14)",
        "prover9": "(A6 -> A14)",
        "prover9_expression": "(trial_terminated(trial_alpha) -> patient_recruitment(trial_alpha))",
        "natural": "In the event that trial alpha has been terminated, patient recruitment for trial alpha has occurred."
      },
      "(A6 → A15)": {
        "formal": "(A6 → A15)",
        "prover9": "(A6 -> A15)",
        "prover9_expression": "(trial_terminated(trial_alpha) -> dosing_complete(trial_alpha))",
        "natural": "If trial alpha has been terminated, then dosing is complete for trial alpha."
      },
      "(A6 → A16)": {
        "formal": "(A6 → A16)",
        "prover9": "(A6 -> A16)",
        "prover9_expression": "(trial_terminated(trial_alpha) -> analysis_complete(trial_alpha))",
        "natural": "Provided that trial alpha has been terminated, analysis is complete for trial alpha."
      },
      "(A6 → ¬A14)": {
        "formal": "(A6 → ¬A14)",
        "prover9": "(A6 -> -A14)",
        "prover9_expression": "(trial_terminated(trial_alpha) -> -patient_recruitment(trial_alpha))",
        "natural": "Should trial alpha be terminated, it is not the case that patient recruitment is complete for trial alpha."
      },
      "(A6 ∨ (A4 → A2))": {
        "formal": "(A6 ∨ (A4 → A2))",
        "prover9": "(A6 | (A4 -> A2))",
        "prover9_expression": "(trial_terminated(trial_alpha) | (safety_established(trial_alpha) -> phase1_complete(trial_alpha)))",
        "natural": "Either trial alpha has been terminated, or if safety has been established for trial alpha, then phase 1 of trial alpha is complete."
      },
      "(A7 → ¬A6)": {
        "formal": "(A7 → ¬A6)",
        "prover9": "(A7 -> -A6)",
        "prover9_expression": "(adverse_events(trial_alpha) -> -trial_terminated(trial_alpha))",
        "natural": "Whenever adverse events occurred in trial alpha, trial alpha is not terminated."
      },
      "(A7 ∨ A8)": {
        "formal": "(A7 ∨ A8)",
        "prover9": "(A7 | A8)",
        "prover9_expression": "(adverse_events(trial_alpha) | funding_withdrawn(trial_alpha))",
        "natural": "Either adverse events occurred in trial alpha or funding was withdrawn from trial alpha."
      },
      "(A8 → ¬A6)": {
        "formal": "(A8 → ¬A6)",
        "prover9": "(A8 -> -A6)",
        "prover9_expression": "(funding_withdrawn(trial_alpha) -> -trial_terminated(trial_alpha))",
        "natural": "Assuming funding was withdrawn from trial alpha, trial alpha is not terminated."
      },
      "(A9 → A10)": {
        "formal": "(A9 → A10)",
        "prover9": "(A9 -> A10)",
        "prover9_expression": "(researcher_certified(dr_smith) -> protocol_followed(trial_alpha))",
        "natural": "If Dr. Smith is certified as a researcher, then the protocol was followed in trial alpha."
      },
      "(A9 → A21)": {
        "formal": "(A9 → A21)",
        "prover9": "(A9 -> A21)",
        "prover9_expression": "(researcher_certified(dr_smith) -> gcp_trained(dr_smith))",
        "natural": "Provided that Dr. Smith is certified as a researcher, Dr. Smith is trained in Good Clinical Practice."
      },
      "(A9 → A22)": {
        "formal": "(A9 → A22)",
        "prover9": "(A9 -> A22)",
        "prover9_expression": "(researcher_certified(dr_smith) -> monitoring_complete(trial_alpha))",
        "natural": "In the event that Dr. Smith is certified as a researcher, monitoring is complete for trial alpha."
      },
      "(A9 → ¬A10)": {
        "formal": "(A9 → ¬A10)",
        "prover9": "(A9 -> -A10)",
        "prover9_expression": "(researcher_certified(dr_smith) -> -protocol_followed(trial_alpha))",
        "natural": "Should Dr. Smith be certified as a researcher, it is not the case that the protocol was followed in trial alpha."
      },
      "(¬(A2 ∨ A3) → A17)": {
        "formal": "(¬(A2 ∨ A3) → A17)",
        "prover9": "(-(A2 | A3) -> A17)",
        "prover9_expression": "(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> trial_extended(trial_alpha))",
        "natural": "If neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then trial alpha has been extended."
      },
      "(¬(A2 ∨ A3) → A19)": {
        "formal": "(¬(A2 ∨ A3) → A19)",
        "prover9": "(-(A2 | A3) -> A19)",
        "prover9_expression": "(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> protocol_modified(trial_alpha))",
        "natural": "Whenever it is not the case that either phase 1 of trial alpha is complete or phase 2 of trial alpha is complete, the protocol was modified for trial alpha."
      },
      "(¬(A2 ∨ A3) → ¬A19)": {
        "formal": "(¬(A2 ∨ A3) → ¬A19)",
        "prover9": "(-(A2 | A3) -> -A19)",
        "prover9_expression": "(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> -protocol_modified(trial_alpha))",
        "natural": "Provided that neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, it is not the case that the protocol was modified for trial alpha."
      },
      "(¬(A9 → A10) → A11)": {
        "formal": "(¬(A9 → A10) → A11)",
        "prover9": "(-(A9 -> A10) -> A11)",
        "prover9_expression": "(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> data_valid(trial_alpha))",
        "natural": "If it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is valid."
      },
      "(¬(A9 → A10) → A28)": {
        "formal": "(¬(A9 → A10) → A28)",
        "prover9": "(-(A9 -> A10) -> A28)",
        "prover9_expression": "(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> publication_pending(trial_alpha))",
        "natural": "Assuming it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, a publication is pending for trial alpha."
      },
      "(¬(A9 → A10) → ¬A11)": {
        "formal": "(¬(A9 → A10) → ¬A11)",
        "prover9": "(-(A9 -> A10) -> -A11)",
        "prover9_expression": "(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha))",
        "natural": "In the event that it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, the data from trial alpha is not valid."
      },
      "(¬(A9 → A22) → A23)": {
        "formal": "(¬(A9 → A22) → A23)",
        "prover9": "(-(A9 -> A22) -> A23)",
        "prover9_expression": "(-(researcher_certified(dr_smith) -> monitoring_complete(trial_alpha)) -> data_audit(trial_alpha))",
        "natural": "Should it not be the case that Dr. Smith is certified as a researcher implying monitoring is complete for trial alpha, then a data audit was conducted for trial alpha."
      },
      "(¬(A9 → A22) → A24)": {
        "formal": "(¬(A9 → A22) → A24)",
        "prover9": "(-(A9 -> A22) -> A24)",
        "prover9_expression": "(-(researcher_certified(dr_smith) -> monitoring_complete(trial_alpha)) -> audit_clean(trial_alpha))",
        "natural": "If it is not the case that Dr. Smith is certified as a researcher implying monitoring is complete for trial alpha, then the audit for trial alpha is clean."
      },
      "(¬(A9 → A22) → ¬A23)": {
        "formal": "(¬(A9 → A22) → ¬A23)",
        "prover9": "(-(A9 -> A22) -> -A23)",
        "prover9_expression": "(-(researcher_certified(dr_smith) -> monitoring_complete(trial_alpha)) -> -data_audit(trial_alpha))",
        "natural": "Provided that it is not the case that Dr. Smith is certified as a researcher implying monitoring is complete for trial alpha, it is not the case that a data audit was conducted for trial alpha."
      },
      "(¬(¬(A2 ∨ A3) → A17) → A18)": {
        "formal": "(¬(¬(A2 ∨ A3) → A17) → A18)",
        "prover9": "(-(-(A2 | A3) -> A17) -> A18)",
        "prover9_expression": "(-(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> trial_extended(trial_alpha)) -> additional_funding(trial_alpha))",
        "natural": "Whenever it is not the case that if neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then trial alpha has been extended, additional funding has been provided for trial alpha."
      },
      "(¬(¬(A2 ∨ A3) → A17) → ¬A18)": {
        "formal": "(¬(¬(A2 ∨ A3) → A17) → ¬A18)",
        "prover9": "(-(-(A2 | A3) -> A17) -> -A18)",
        "prover9_expression": "(-(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> trial_extended(trial_alpha)) -> -additional_funding(trial_alpha))",
        "natural": "Should it not be the case that if neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then trial alpha has been extended, it is not the case that additional funding has been provided for trial alpha."
      },
      "(¬(¬(A2 ∨ A3) → ¬A19) → A20)": {
        "formal": "(¬(¬(A2 ∨ A3) → ¬A19) → A20)",
        "prover9": "(-(-(A2 | A3) -> -A19) -> A20)",
        "prover9_expression": "(-(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> -protocol_modified(trial_alpha)) -> new_endpoints(trial_alpha))",
        "natural": "Assuming it is not the case that if neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then it is not the case that the protocol was modified for trial alpha, new endpoints were established for trial alpha."
      },
      "(¬(¬(A2 ∨ A3) → ¬A19) → ¬A20)": {
        "formal": "(¬(¬(A2 ∨ A3) → ¬A19) → ¬A20)",
        "prover9": "(-(-(A2 | A3) -> -A19) -> -A20)",
        "prover9_expression": "(-(-(phase1_complete(trial_alpha) | phase2_complete(trial_alpha)) -> -protocol_modified(trial_alpha)) -> -new_endpoints(trial_alpha))",
        "natural": "In the event that it is not the case that if neither phase 1 of trial alpha is complete nor phase 2 of trial alpha is complete, then it is not the case that the protocol was modified for trial alpha, it is not the case that new endpoints were established for trial alpha."
      },
      "(¬(¬(A9 → A10) → ¬A11) → A12)": {
        "formal": "(¬(¬(A9 → A10) → ¬A11) → A12)",
        "prover9": "(-(-(A9 -> A10) -> -A11) -> A12)",
        "prover9_expression": "(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> regulatory_approval(trial_alpha))",
        "natural": "Provided that it is not the case that if it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is not valid, regulatory approval has been granted for trial alpha."
      },
      "(¬(¬(A9 → A10) → ¬A11) → A13)": {
        "formal": "(¬(¬(A9 → A10) → ¬A11) → A13)",
        "prover9": "(-(-(A9 -> A10) -> -A11) -> A13)",
        "prover9_expression": "(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> fast_track_status(trial_alpha))",
        "natural": "If it is not the case that if it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is not valid, trial alpha has fast-track status."
      },
      "(¬(¬(A9 → A10) → ¬A11) → A25)": {
        "formal": "(¬(¬(A9 → A10) → ¬A11) → A25)",
        "prover9": "(-(-(A9 -> A10) -> -A11) -> A25)",
        "prover9_expression": "(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> market_approval(drug_x))",
        "natural": "Should it not be the case that if it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is not valid, market approval has been granted for drug X."
      },
      "(¬(¬(A9 → A10) → ¬A11) → ¬A12)": {
        "formal": "(¬(¬(A9 → A10) → ¬A11) → ¬A12)",
        "prover9": "(-(-(A9 -> A10) -> -A11) -> -A12)",
        "prover9_expression": "(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> -regulatory_approval(trial_alpha))",
        "natural": "Whenever it is not the case that if it is not the case that Dr. Smith is certified as a researcher implying the protocol was followed in trial alpha, then the data from trial alpha is not valid, it is not the case that regulatory approval has been granted for trial alpha."
      },
      "(¬(¬(¬(A9 → A10) → ¬A11) → A25) → A26)": {
        "formal": "(¬(¬(¬(A9 → A10) → ¬A11) → A25) → A26)",
        "prover9": "(-(-(-(A9 -> A10) -> -A11) -> A25) -> A26)",
        "prover9_expression": "(-(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> market_approval(drug_x)) -> patent_filed(drug_x))",
        "natural": "Assuming it is not the case that if it is not the case that whenever Dr. Smith is certified as a researcher, the protocol was followed in trial alpha, and this leads to the data from trial alpha not being valid, then market approval for drug X results, a patent has been filed for drug X."
      },
      "(¬(¬(¬(A9 → A10) → ¬A11) → A25) → ¬A26)": {
        "formal": "(¬(¬(¬(A9 → A10) → ¬A11) → A25) → ¬A26)",
        "prover9": "(-(-(-(A9 -> A10) -> -A11) -> A25) -> -A26)",
        "prover9_expression": "(-(-(-(researcher_certified(dr_smith) -> protocol_followed(trial_alpha)) -> -data_valid(trial_alpha)) -> market_approval(drug_x)) -> -patent_filed(drug_x))",
        "natural": "In the event that it is not the case that if it is not the case that whenever Dr. Smith is certified as a researcher, the protocol was followed in trial alpha, and this leads to the data from trial alpha not being valid, then market approval for drug X results, it is not the case that a patent has been filed for drug X."
      },
      "(¬G → A1)": {
        "formal": "(¬G → A1)",
        "prover9": "(-G -> A1)",
        "prover9_expression": "(-fda_oversight(trial_alpha) -> approved(drug_x))",
        "natural": "If there is no FDA oversight for trial alpha, then drug X is approved."
      },
      "(¬G → A9)": {
        "formal": "(¬G → A9)",
        "prover9": "(-G -> A9)",
        "prover9_expression": "(-fda_oversight(trial_alpha) -> researcher_certified(dr_smith))",
        "natural": "Provided there is no FDA oversight for trial alpha, Dr. Smith is certified as a researcher."
      },
      "(¬G → ¬A1)": {
        "formal": "(¬G → ¬A1)",
        "prover9": "(-G -> -A1)",
        "prover9_expression": "(-fda_oversight(trial_alpha) -> -approved(drug_x))",
        "natural": "Should there be no FDA oversight for trial alpha, drug X is not approved."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "fda_oversight(trial_alpha)",
        "natural": "There is FDA oversight for trial alpha."
      },
      "¬A17": {
        "formal": "¬A17",
        "prover9": "-A17",
        "prover9_expression": "-trial_extended(trial_alpha)",
        "natural": "It is not the case that trial alpha has been extended."
      },
      "¬A21": {
        "formal": "¬A21",
        "prover9": "-A21",
        "prover9_expression": "-gcp_trained(dr_smith)",
        "natural": "It is not the case that Dr. Smith is trained in Good Clinical Practice."
      },
      "¬A27": {
        "formal": "¬A27",
        "prover9": "-A27",
        "prover9_expression": "-competitor_advantage(drug_y)",
        "natural": "It is not the case that competitor drug Y has an advantage."
      },
      "¬A29": {
        "formal": "¬A29",
        "prover9": "-A29",
        "prover9_expression": "-conference_presentation(trial_alpha)",
        "natural": "It is not the case that a conference presentation was made for trial alpha."
      },
      "¬A6": {
        "formal": "¬A6",
        "prover9": "-A6",
        "prover9_expression": "-trial_terminated(trial_alpha)",
        "natural": "It is not the case that trial alpha has been terminated."
      },
      "¬A9": {
        "formal": "¬A9",
        "prover9": "-A9",
        "prover9_expression": "-researcher_certified(dr_smith)",
        "natural": "It is not the case that Dr. Smith is certified as a researcher."
      }
    }
  }
}